EU Regulator To Re-Examine Safety Of Common Drugs
Europe's top drug agency has launched another review of commonly used anti-inflammatory drugs amid concerns over a link to heightened risk of heart attacks....To view the full article, register now.
Already a subscriber? Click here to view full article